Fund Holdings — TAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value
$16.37M
Total Bought
$527.5K
Total Sold
$13.90M
Net Transaction
-$13.38M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Ovid Therapeutics, Inc.(OVID)7,531,9967,531,99602,4859,79259.82%+7,306
Equillium, Inc.(EQ)1,824,9771,824,97705752,61015.94%+2,034
Shattuck Labs, Inc.(STTK)515,619515,61904081,2327.53%+824
Lyell Immunopharma, Inc.(LYEL)41,16554,887+13,7223648915.45%+527
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)(XLO)1,475,1211,475,12101,0031,2437.59%+240
Standard Biotools, Inc.(LAB)16,51516,515020210.13%+2
Rani Therapeutics Holdings, Inc.(RANI)203,190203,19001041020.62%-3
Third Harmonic Bio, Inc.36,8350-36,8352000—-200
American Well Corporation(AMWL)77,73377,73306914782.92%-213
Turnstone Biologics895,8240-895,8243220—-322
HilleVax, Inc.6,724,0000-6,724,00013,3810—-13,381
Page 1 of 1
TAKEDA PHARMACEUTICAL CO LTD — 13F Holdings — Q3 2025 | TickerTrail